Awakn Life Sciences Corp.

News & Events

Press Releases

In The Media

1. Awakn Life Sciences Announces Shareholder Approval of Arrangement

   Newsfile APR 23, 2025 7:30 AM EDT
   Toronto, Ontario--(Newsfile Corp. - April 23, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC ...
   READ ARTICLE

2. Awakn Life Sciences Provides Supplemental Disclosure in Connection with Proposed Plan of Arrangement

   Newsfile APR 11, 2025 7:30 AM EDT
   Toronto, Ontario--(Newsfile Corp. - April 11, 2025) - Further to its press release dated February...
   READ ARTICLE

3. Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc

   Newsfile FEB 27, 2025 9:16 AM EST
   Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (O...
   READ ARTICLE

4. Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD

   Newsfile JAN 27, 2025 2:00 AM EST
   Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OT...
   READ ARTICLE

5. Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder

   Newsfile JAN 20, 2025 5:00 PM EST
   Toronto, Ontario--(Newsfile Corp. - January 20, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (...
   READ ARTICLE

6. Awakn Life Sciences Announces Credit Facility

   Newsfile DEC 18, 2024 8:30 AM EST
   Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (O...
   READ ARTICLE

7. Canadian Investment Regulatory Organization Trading Halt - AWKN

   Canada Newswire DEC 16, 2024 8:40 AM EST
   Canadian Investment Regulatory Organization Trading Halt - AWKN Canada NewsWire ...
   READ ARTICLE

8. Awakn Life Sciences Enters into Binding Letter of Intent for Acquisition of Awakn by Graft Polymer (UK) Plc

   Newsfile DEC 16, 2024 8:30 AM EST
   Toronto, Ontario--(Newsfile Corp. - December 16, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (O...
   READ ARTICLE

9. Awakn Announces Promising Results from Aminoindane New Chemical Entity Pre-Clinical Program

   Newsfile DEC 10, 2024 5:30 PM EST
   Toronto, Ontario--(Newsfile Corp. - December 10, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (O...
   READ ARTICLE

10. Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites

    Newsfile OCT 22, 2024 7:30 AM EDT
    Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OT...
    READ ARTICLE